Suma Krishnan, Chief Operating Officer at Krystal Biotech, Inc. (KRYS), sold 100,000 shares at $46.24 ($4.6M) on 2020-09-16, disclosed to the SEC on 2020-09-17.
Open-market sale of $4.6M KRYS by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.21 | 14,435 | $667K | 14.4% |
| 2 | $46.21 | 14,435 | $667K | 14.4% |
| 3 | $47.15 | 1,517 | $72K | 1.5% |
| 4 | $47.15 | 1,517 | $72K | 1.5% |
| 5 | $46.24 | 9,749 | $451K | 9.7% |
| 6 | $46.24 | 9,749 |
| $451K |
| 9.7% |
| 7 | $46.85 | 5,142 | $241K | 5.2% |
| 8 | $46.85 | 5,142 | $241K | 5.2% |
| 9 | $46.09 | 10,594 | $488K | 10.5% |
| 10 | $46.09 | 10,594 | $488K | 10.5% |
| 11 | $46.63 | 7,437 | $347K | 7.5% |
| 12 | $46.63 | 7,437 | $347K | 7.5% |
| 13 | $47.29 | 1,126 | $53K | 1.1% |
| 14 | $47.29 | 1,126 | $53K | 1.1% |
| Total | $46.37 avg | 100,000 | $4.6M | 100% |
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |